Leveraging crowdsourcing to facilitate the discovery of new medicines.


Gloomy predictions about the future of pharma have forced the industry to investigate alternative models of drug discovery. Public-private partnerships (PPPs) have the potential to revitalize the discovery and development of first-in-class therapeutics. The new PPP Arch2POCM hopes to foster biomedical innovation through precompetitive validation of pioneer… (More)
DOI: 10.1126/scitranslmed.3002678


1 Figure or Table

Cite this paper

@article{Norman2011LeveragingCT, title={Leveraging crowdsourcing to facilitate the discovery of new medicines.}, author={Thea Norman and Chas Bountra and Aled M. Edwards and Keith R. Yamamoto and Stephen H. Friend}, journal={Science translational medicine}, year={2011}, volume={3 88}, pages={88mr1} }